Equasens drops after Q2 results
30/09/2024 09:07
** Shares in Equasens EQSE.PA fall around 6% after the
French healthcare IT solutions provider reported Q2 results
** Operating income was 20.9 million euros in Q2, down 24%
year-on-year and "well below our expectations", Portzamparc says
in a note
** "Most of the difference with our estimates relates to the
Pharmagest division, which saw its H1 operating profit fall by
23.5% to 14.1 million euros," Portzamparc adds
** Forecast confirmation with a return to revenue growth
starting in H2 and an acceleration in 2025 remains vague about
the scale, broker notes
(Reporting by Mathias de Rozario)
((mathias.derozario@thomsonreuters.com))